{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:13:10Z","timestamp":1786122790754,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science and Technological Research Fund of Guangdong Province","award":["B2025123"],"award-info":[{"award-number":["B2025123"]}]},{"name":"Medical Science and Technological Research Fund of Guangdong Province","award":["B2026109"],"award-info":[{"award-number":["B2026109"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302446"],"award-info":[{"award-number":["82302446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2022A1515012413, 2024A1515012890, 2026A1515012073"],"award-info":[{"award-number":["2022A1515012413, 2024A1515012890, 2026A1515012073"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Youth Topnotch Talent of Guangdong TeZhi Plan","award":["2024TQ08A155"],"award-info":[{"award-number":["2024TQ08A155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12525-z","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:02:44Z","timestamp":1786104164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR75 mediates hyperuricemia-induced endothelial inflammatory injury via a HOTAIR\/miR-141-3p regulatory network"],"prefix":"10.1007","volume":"53","author":[{"given":"Jiawu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiekai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"7","key":"12525_CR1","first-page":"3167","volume":"12","author":"L Li","year":"2020","unstructured":"Li L, Zhang Y, Zeng C (2020) Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res 12(7):3167\u20133181","journal-title":"Am J Transl Res"},{"issue":"2","key":"12525_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4078\/jrd.2022.0001","volume":"30","author":"JK Ahn","year":"2023","unstructured":"Ahn JK (2023) Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean. J Rheum Dis 30(2):88\u201398. https:\/\/doi.org\/10.4078\/jrd.2022.0001","journal-title":"J Rheum Dis"},{"issue":"5","key":"12525_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1080\/14397595.2019.1660048","volume":"30","author":"X Dong","year":"2020","unstructured":"Dong X, Zhang H, Wang F, Liu X, Yang K, Tu R, Wei M, Wang L, Mao Z, Zhang G, Wang C (2020) Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: The Henan Rural Cohort Study. Mod Rheumatol 30(5):910\u2013920. https:\/\/doi.org\/10.1080\/14397595.2019.1660048","journal-title":"Mod Rheumatol"},{"issue":"10","key":"12525_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.59556\/japi.71.0364","volume":"71","author":"B Patni","year":"2023","unstructured":"Patni B, Singh AN, Singh NK, Patil A, Kapoor A, Jagadeesha A, Saxena A, Ghosh B, Agarwal D, Shah KR, Aslam M, Sheohare R, Sengupta S, Verma N (2023) Prevalence of Hyperuricemia in Indian Population with Hypertension. J Assoc Physicians India 71(10):45\u201348. https:\/\/doi.org\/10.59556\/japi.71.0364","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"12525_CR5","doi-asserted-by":"publisher","first-page":"105286","DOI":"10.1016\/j.jbspin.2021.105286","volume":"89","author":"T Bardin","year":"2022","unstructured":"Bardin T, Magnat E, Clerson P, Richette P, Rouchon B (2022) Epidemiology of gout and hyperuricemia in New Caledonia. Joint Bone Spine 89(2):105286. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105286","journal-title":"Joint Bone Spine"},{"issue":"2","key":"12525_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/ham.2022.0133","volume":"24","author":"Z Song","year":"2023","unstructured":"Song Z, Zhang A, Luo J, Xiong G, Peng H, Zhou R, Li Y, Xu H, Li Z, Zhao W, Zhang H (2023) Prevalence of High-Altitude Polycythemia and Hyperuricemia and Risk Factors for Hyperuricemia in High-Altitude Immigrants. High Alt Med Biol 24(2):132\u2013138. https:\/\/doi.org\/10.1089\/ham.2022.0133","journal-title":"High Alt Med Biol"},{"key":"12525_CR7","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.2147\/DMSO.S344894","volume":"14","author":"Z Eljaaly","year":"2021","unstructured":"Eljaaly Z, Mujammami M, Nawaz SS, Rafiullah M, Siddiqui K (2021) Risk Predictors of High Uric Acid Levels Among Patients with Type-2 Diabetes. Diabetes Metab Syndr Obes 14:4911\u20134920. https:\/\/doi.org\/10.2147\/DMSO.S344894","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"12525_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4140\/TCP.n.2025.365","volume":"40","author":"MW Carter","year":"2025","unstructured":"Carter MW, Roman YM (2025) Perspectives on the Epidemiology of Hyperuricemia and Gout in Older Adults. Sr Care Pharm 40(9):365\u2013372. https:\/\/doi.org\/10.4140\/TCP.n.2025.365","journal-title":"Sr Care Pharm"},{"key":"12525_CR9","doi-asserted-by":"publisher","first-page":"1658286","DOI":"10.3389\/fnut.2025.1658286","volume":"12","author":"P Liu","year":"2025","unstructured":"Liu P, Kadier K, Wu X, Sun X, Zhang G, Liu X, Song D, Cui C (2025) Association between higher estimated glucose disposal rate and reduced prevalence of hyperuricemia and gout. Front Nutr 12:1658286. https:\/\/doi.org\/10.3389\/fnut.2025.1658286","journal-title":"Front Nutr"},{"issue":"1","key":"12525_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12872-025-04529-7","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Pang Y, Shen J, Chen W, Hao C, Lei Z (2025) The new definition of metabolic syndrome including hyperuricemia improves its prognostic value: results from NHANES database. BMC Cardiovasc Disord 25(1):93. https:\/\/doi.org\/10.1186\/s12872-025-04529-7","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"12525_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/art.43118","volume":"77","author":"R Terkeltaub","year":"2025","unstructured":"Terkeltaub R, Dodd D (2025) The Gut Microbiome in Hyperuricemia and Gout. Arthritis Rheumatol 77(8):955\u2013965. https:\/\/doi.org\/10.1002\/art.43118","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"12525_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/ijmm.2016.2491","volume":"37","author":"P Li","year":"2016","unstructured":"Li P, Zhang L, Zhang M, Zhou C, Lin N (2016) Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: A mechanism for uric acid-induced endothelial dysfunction. Int J Mol Med 37(4):989\u2013997. https:\/\/doi.org\/10.3892\/ijmm.2016.2491","journal-title":"Int J Mol Med"},{"issue":"22","key":"12525_CR13","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.3390\/foods14223843","volume":"14","author":"X Zhou","year":"2025","unstructured":"Zhou X, Liu T, Xu B, Zhang W, Li X, Wei F, Lv H, Ji X, Zhang B, Wang S (2025) Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes. Foods 14(22):3843. https:\/\/doi.org\/10.3390\/foods14223843","journal-title":"Foods"},{"key":"12525_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashi","year":"2018","unstructured":"Maruhashi T, Hisatome I, Kihara Y, Higashi Y (2018) Hyperuricemia and endothelial function: From molecular background to clinical perspectives. Atherosclerosis 278:226\u2013231. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.10.007","journal-title":"Atherosclerosis"},{"issue":"8","key":"12525_CR15","first-page":"e43361","volume":"15","author":"TJ Ubhadiya","year":"2023","unstructured":"Ubhadiya TJ, Dubey N, Sojitra MH, Shah K, Joshi S, Gandhi SK, Patel P (2023) Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia. Cureus 15(8):e43361","journal-title":"Cureus"},{"key":"12525_CR16","doi-asserted-by":"publisher","first-page":"111932","DOI":"10.1016\/j.intimp.2024.111932","volume":"132","author":"S Yang","year":"2024","unstructured":"Yang S, Liu H, Fang XM, Yan F, Zhang Y (2024) Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions. Int Immunopharmacol 132:111932. https:\/\/doi.org\/10.1016\/j.intimp.2024.111932","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"12525_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41440-023-01273-3","volume":"46","author":"M Kuwabara","year":"2023","unstructured":"Kuwabara M, Kodama T, Ae R, Kanbay M, Andres-Hernando A, Borghi C, Hisatome I, Lanaspa MA (2023) Update in uric acid, hypertension, and cardiovascular diseases. Hypertens Res 46(7):1714\u20131726. https:\/\/doi.org\/10.1038\/s41440-023-01273-3","journal-title":"Hypertens Res"},{"key":"12525_CR18","doi-asserted-by":"publisher","first-page":"132527","DOI":"10.1016\/j.ijcard.2024.132527","volume":"417","author":"A Maloberti","year":"2024","unstructured":"Maloberti A, Tognola C, Garofani I, Algeri M, Shkodra A, Bellantonio V, Le Van M, Pedroli S, Campana M, Toscani G, Bombelli M, Giannattasio C (2024) Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off. Int J Cardiol 417:132527. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132527","journal-title":"Int J Cardiol"},{"issue":"7","key":"12525_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1507\/endocrj.EJ18-0570","volume":"66","author":"J Liu","year":"2019","unstructured":"Liu J, Wang K, Liu H, Zhao H, Zhao X, Lan Y, Huang W, Wang H (2019) Relationship between carotid-femoral pulse wave velocity and uric acid in subjects with hypertension and hyperuricemia. Endocr J 66(7):629\u2013636. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0570","journal-title":"Endocr J"},{"key":"12525_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2022.02.003","volume":"94","author":"G Froogh","year":"2022","unstructured":"Froogh G, Garcia V, Laniado Schwartzman M (2022) The CYP\/20-HETE\/GPR75 axis in hypertension. Adv Pharmacol 94:1\u201325. https:\/\/doi.org\/10.1016\/bs.apha.2022.02.003","journal-title":"Adv Pharmacol"},{"issue":"18","key":"12525_CR21","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1111\/bph.15525","volume":"178","author":"JV Pascale","year":"2021","unstructured":"Pascale JV, Park EJ, Adebesin AM, Falck JR, Laniado Schwartzman M, Garcia V (2021) Uncovering the signalling, structure and function of the 20-HETE-GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75. Br J Pharmacol 178(18):3813\u20133828. https:\/\/doi.org\/10.1111\/bph.15525","journal-title":"Br J Pharmacol"},{"key":"12525_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biochi","volume":"195","author":"B Murtaza","year":"2022","unstructured":"Murtaza B, Asghar F, Patoli D (2022) GPR75: An exciting new target in metabolic syndrome and related disorders. Biochimie 195:19\u201326. https:\/\/doi.org\/10.1016\/j.biochi","journal-title":"Biochimie"},{"issue":"2","key":"12525_CR23","doi-asserted-by":"publisher","first-page":"158573","DOI":"10.1016\/j.bbalip.2019.158573","volume":"1865","author":"S C\u00e1rdenas","year":"2020","unstructured":"C\u00e1rdenas S, Colombero C, Panelo L, Dakarapu R, Falck JR, Costas MA, Nowicki S (2020) GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells. Biochim Biophys Acta Mol Cell Biol Lipids 1865(2):158573. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158573","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"11","key":"12525_CR24","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","volume":"120","author":"V Garcia","year":"2017","unstructured":"Garcia V, Gilani A, Shkolnik B, Pandey V, Zhang FF, Dakarapu R, Gandham SK, Reddy NR, Graves JP, Gruzdev A, Zeldin DC, Capdevila JH, Falck JR, Laniado Schwartzman M (2017) 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension. Circ Res 120(11):1776\u20131788. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.310525","journal-title":"Circ Res"},{"issue":"3","key":"12525_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/HJH.0000000000003038","volume":"40","author":"K Agostinucci","year":"2022","unstructured":"Agostinucci K, Hutcheson R, Hossain S, Pascale JV, Villegas E, Zhang F, Adebesin AM, Falck JR, Gupte S, Garcia V, Laniado Schwartzman M (2022) Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase. J Hypertens 40(3):498\u2013511. https:\/\/doi.org\/10.1097\/HJH.0000000000003038","journal-title":"J Hypertens"},{"key":"12525_CR26","doi-asserted-by":"publisher","first-page":"157613","DOI":"10.1016\/j.phymed.2025.157613","volume":"150","author":"P Tang","year":"2026","unstructured":"Tang P, Jiang H, Zheng Z, Xiao Z, Kong L, Luo J (2026) Limonoid walrobsin A alleviates LPS-induced septic acute kidney injury through modulating inflammatory microenvironment by targeting G protein-coupled receptor 75. Phytomedicine 150:157613. https:\/\/doi.org\/10.1016\/j.phymed.2025.157613","journal-title":"Phytomedicine"},{"issue":"4","key":"12525_CR27","doi-asserted-by":"publisher","first-page":"e71579","DOI":"10.1096\/fj.202504597R","volume":"40","author":"S Hossain","year":"2026","unstructured":"Hossain S, Villegas E, Liapes C, Sultana N, Krasniqi D, Diegisser D, Castro A, Williams C, Gruzdev A, Zeldin DC, Garcia V, Laniado Schwartzman M (2026) Gpr75 Deletion in Adipocytes Protects From Diet-Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses. FASEB J 40(4):e71579. https:\/\/doi.org\/10.1096\/fj.202504597R","journal-title":"FASEB J"},{"issue":"1","key":"12525_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11033-026-11490-x","volume":"53","author":"N Nademi","year":"2026","unstructured":"Nademi N, Ozfiliz-Kilbas P (2026) The CeRNA role of HOTAIR: sponging MiRs to promote chemoresistance. Mol Biol Rep 53(1):319. https:\/\/doi.org\/10.1007\/s11033-026-11490-x","journal-title":"Mol Biol Rep"},{"key":"12525_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18632\/oncoscience.563","volume":"9","author":"S Garbo","year":"2022","unstructured":"Garbo S, Tripodi M, Battistelli C (2022) lncRNA HOTAIR functions and therapeutic perspectives. Oncoscience 9:49\u201351. https:\/\/doi.org\/10.18632\/oncoscience.563","journal-title":"Oncoscience"},{"issue":"1","key":"12525_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2025.2475255","volume":"22","author":"J Xie","year":"2025","unstructured":"Xie J, Zheng Z, Wang B, Zhang J, Jiang J, Wu F, Zhong X, Chen J (2025) LncRNA HOTAIR promotes aerobic glycolysis by recruiting Lin28 to induce inflammation and apoptosis in acute lung injury. RNA Biol 22(1):1\u201312. https:\/\/doi.org\/10.1080\/15476286.2025.2475255","journal-title":"RNA Biol"},{"issue":"1","key":"12525_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41419-020-2247-0","volume":"11","author":"B Jiang","year":"2020","unstructured":"Jiang B, Tang Y, Wang H, Chen C, Yu W, Sun H, Duan M, Lin X, Liang P (2020) Down-regulation of long non-coding RNA HOTAIR promotes angiogenesis via regulating miR-126\/SCEL pathways in burn wound healing. Cell Death Dis 11(1):61. https:\/\/doi.org\/10.1038\/s41419-020-2247-0","journal-title":"Cell Death Dis"},{"issue":"1","key":"12525_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/etm.2021.11022","volume":"23","author":"Y Wang","year":"2022","unstructured":"Wang Y, Mao J, Li X, Wang B, Zhou X (2022) lncRNA HOTAIR mediates OGD\/R-induced cell injury and angiogenesis in a EZH2-dependent manner. Exp Ther Med 23(1):99. https:\/\/doi.org\/10.3892\/etm.2021.11022","journal-title":"Exp Ther Med"},{"issue":"6","key":"12525_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/08820139.2025.2503174","volume":"54","author":"J He","year":"2025","unstructured":"He J, Shao Z, Li Z, He Y, Zhang J, Zhong H, Li J, Liu Q, Shao Y (2025) Mechanistic Insights into HOTAIR-Driven ADAM17\/NF-\u039ab Activation and Endothelial Dysfunction in LPS-Challenged HUVECs. Immunol Invest 54(6):867\u2013893. https:\/\/doi.org\/10.1080\/08820139.2025.2503174","journal-title":"Immunol Invest"},{"key":"12525_CR34","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005","journal-title":"Elife"},{"issue":"6","key":"12525_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41592-026-03105-x","volume":"23","author":"K Zhou","year":"2026","unstructured":"Zhou K, Huang J, Liu S, Zheng W, Liu S, Xing Y, Cao Y, Chen Y, Hu X, Cai L, Zhou J, Lin P, Xuan J, Xie F, Xu L, Li J, Zheng L, Qu L, Chen J, Li B, Yang J (2026) An encyclopedic regulatory and functional atlas of RNA interactomes. Nat Methods 23(6):1109\u20131114. https:\/\/doi.org\/10.1038\/s41592-026-03105-x","journal-title":"Nat Methods"},{"issue":"2","key":"12525_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.18632\/aging.205430","volume":"16","author":"Y Zhan","year":"2024","unstructured":"Zhan Y, Li L, Guo C, Zhang Y, Zhao L, Tao Z, Zhang H, Chen S (2024) MicroRNA-141-3p reduces pulmonary hypoxia\/reoxygenation injury through suppression of Beclin-1-dependent autophagy. Aging 16(2):1352\u20131373. https:\/\/doi.org\/10.18632\/aging.205430","journal-title":"Aging"},{"key":"12525_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jocn.2022.03.010","volume":"99","author":"M Yu","year":"2022","unstructured":"Yu M, Tian T, Zhang J, Hu T (2022) miR-141-3p protects against blood-brain barrier disruption and brain injury after intracerebral hemorrhage by targeting ZEB2. J Clin Neurosci 99:253\u2013260. https:\/\/doi.org\/10.1016\/j.jocn.2022.03.010","journal-title":"J Clin Neurosci"},{"issue":"1","key":"12525_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s10020-025-01246-x","volume":"31","author":"D Peng","year":"2025","unstructured":"Peng D, He X, Ren B, Wang Q, Peng L, Jiang Y, Huo S, Men L, Shi W, Luo P, Zhu M, Zhang C, Lv J, Lin L, Li S (2025) JAK2\/STAT3\/HMGCS2 signaling aggravates mitochondrial dysfunction and oxidative stress in hyperuricemia-induced cardiac dysfunction. Mol Med 31(1):184. https:\/\/doi.org\/10.1186\/s10020-025-01246-x","journal-title":"Mol Med"},{"issue":"6","key":"12525_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/br.2024.1859","volume":"21","author":"S Dogru","year":"2024","unstructured":"Dogru S, Yasar E, Yesilkaya A (2024) Effects of uric acid on oxidative stress in vascular smooth muscle cells. Biomed Rep 21(6):171. https:\/\/doi.org\/10.3892\/br.2024.1859","journal-title":"Biomed Rep"},{"issue":"3","key":"12525_CR40","doi-asserted-by":"publisher","first-page":"H603","DOI":"10.1152\/ajpheart.00681.2024","volume":"328","author":"M Abbas","year":"2025","unstructured":"Abbas M, Gaye A (2025) Emerging roles of noncoding RNAs in cardiovascular pathophysiology. Am J Physiol Heart Circ Physiol 328(3):H603\u2013H621. https:\/\/doi.org\/10.1152\/ajpheart.00681.2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"12525_CR41","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/0929867330666230213100732","volume":"31","author":"S Ouyang","year":"2024","unstructured":"Ouyang S, Zhou ZX, Liu HT, Ren Z, Liu H, Deng NH, Tian KJ, Zhou K, Xie HL, Jiang ZS (2024) LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic Disease. Curr Med Chem 31(10):1251\u20131264","journal-title":"Curr Med Chem"},{"key":"12525_CR42","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.redox.2021.102108","volume":"46","author":"TS Lee","year":"2021","unstructured":"Lee TS, Lu TM, Chen CH, Guo BC, Hsu CP (2021) Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine\/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol 46:102108. https:\/\/doi.org\/10.1016\/j.redox.2021.102108","journal-title":"Redox Biol"},{"issue":"6","key":"12525_CR43","doi-asserted-by":"publisher","first-page":"e70437","DOI":"10.1096\/fj.202402831R","volume":"39","author":"J Zhang","year":"2025","unstructured":"Zhang J, Lei W, Zhou J, Zhang Y, Huang F, Chen M (2025) Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction. FASEB J 39(6):e70437. https:\/\/doi.org\/10.1096\/fj.202402831R","journal-title":"FASEB J"},{"issue":"2","key":"12525_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.numecd.2014.08.006","volume":"25","author":"WY Liang","year":"2015","unstructured":"Liang WY, Zhu XY, Zhang JW, Feng XR, Wang YC, Liu ML (2015) Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling. Nutr Metab Cardiovasc Dis 25(2):187\u2013194. https:\/\/doi.org\/10.1016\/j.numecd.2014.08.006","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"12525_CR45","doi-asserted-by":"publisher","first-page":"e0300","DOI":"10.1097\/XCE.0000000000000300","volume":"13","author":"TM Gan","year":"2024","unstructured":"Gan TM, Ye YY, Mo GL, Li JY (2024) Progress of uric acid in cardiovascular disease. Cardiovasc Endocrinol Metab 13(2):e0300. https:\/\/doi.org\/10.1097\/XCE.0000000000000300","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"12525_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","volume":"484","author":"G Ndrepepa","year":"2018","unstructured":"Ndrepepa G (2018) Uric acid and cardiovascular disease. Clin Chim Acta 484:150\u2013163. https:\/\/doi.org\/10.1016\/j.cca.2018.05.046","journal-title":"Clin Chim Acta"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12525-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:02:46Z","timestamp":1786104166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12525-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12525"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12525-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experimental protocols were reviewed and approved by the Animal Ethics Committee of Guangzhou Meyers Biotechnology (IACUC-MIS20230032), and were performed according to the National Institutes of Health guidelines for the care and use of laboratory animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1356"}}